Sort
23,748 grants matching “melanoma”
Spatial-Genomic Integrative Multi-Species Analysis of Lymph Node Metastasis
$480,746Sylvia Katina Plevritis · Stanford University · U54 · FY2021 · CA
Modifying Young Adult Skin Cancer Risk and Protective Behaviors (UV4.me2):A Hybrid Type 2 Dissemination/Effectiveness Trial
$480,695Carolyn J. Heckman · Rbhs -Cancer Institute Of New Jersey · R01 · FY2021 · CA
Salicylic acid-based small-molecule Stat3 inhibitors for anticancer therapy
$480,634James K Turkson · University Of Hawaii At Manoa · R01 · FY2016 · CA
Salicylic acid-based small-molecule Stat3 inhibitors for anticancer therapy
$480,634James K Turkson · University Of Hawaii At Manoa · R01 · FY2015 · CA
Multidisciplinary Collaborative Research in NIDDK Program Area Diseases
$480,623James Balow · National Institute Of Diabetes And Digestive And Kidney Diseases · Z01 · FY2008 · DK
Targeting Oncogene Expression to Skin in Transgenic Mice
$480,576Dennis Roop · University Of Colorado Denver · R01 · FY2011 · CA
Development of Methods for Cancer Biomarker Detection
$480,464Wistar Institute · R33 · FY2003 · CA
Repurposing TRM for tumor immunotherapy
$480,356David Masopust · University Of Minnesota · R01 · FY2022 · CA
Repurposing TRM for tumor immunotherapy
$480,356David Masopust · University Of Minnesota · R01 · FY2023 · CA
The Development of Thermally-activated Metalloenediynes for Cancer Therapy
$480,334Joseph R Dynlacht · Indiana University Indianapolis · R01 · FY2015 · CA
The Extracellular Matrix as a Determinant of Filovirus Infectivity.
$480,249Ronald N. Harty · University Of Pennsylvania · R21 · FY2025 · AI
Defining the role of NF1 and SPRED1 loss in melanoma
$480,247Iwei Yeh · University Of California, San Francisco · R37 · FY2024 · CA
National Clinical Trials Network (NCTN) - Lead Academic Participating Site (LAPS)
$480,167Lawrence E Flaherty · Wayne State University · UG1 · FY2025 · CA
Palliative Care: Maximizing Patient Preference
$480,056Donald H Taylor · Duke University · R01 · FY2011 · HS
Cellular mechanisms by which exhausted T cell responses are restored
$480,042Thorsten Roman Mempel · Massachusetts General Hospital · R01 · FY2022 · AI
Repression of Inflammasome by Francisella tularensis
$480,000Meenakshi Malik · Albany College Of Pharmacy · R15 · FY2017 · AI
Canine models for characterization, diagnosis, and treatment of human cancers using comparative canine-human transcriptomics
$480,000Gregory Tawa · National Center For Advancing Translational Sciences · ZIA · FY2025 · TR
Chemical Probes to Study Copper Biology
$479,957Christopher J. Chang · Princeton University · R01 · FY2025 · GM
Targeting Podoplanin to Prevent and Combat Oral Cancer
$479,927Gary S Goldberg · Rowan University School/Osteopathic Med · R15 · FY2019 · CA
The role of regulation and subcellular localization of GTP biosynthesis in melanoma invasion and metastasis
$479,923Mikhail Nikiforov · Duke University · R01 · FY2024 · CA
Modulation of asparagine bioavailability and stress response signaling to enhance T cell robustness and maximize immunotherapy
$479,843Ruoning Wang · Research Inst Nationwide Children'S Hosp · R01 · FY2025 · CA
Project 1 Targeting the PI3K Pathway to Overcome Resistance to Immunotherapy in Melanomas with Loss of PTEN
$479,648Michael Davies · University Of Tx Md Anderson Can Ctr · P50 · FY2023 · CA
Regulation of metastatic progression by an endothelial-derived factor
$479,624Sohail F. Tavazoie · Rockefeller University · R01 · FY2020 · CA
Regulation of Lymphocyte Proliferation and Replicative Capacity
$479,513Richard J. Hodes · Division Of Basic Sciences - Nci · ZIA · FY2012 · CA
Melanoma: Metabolic Biomarkers of Response to Targeted Therapy
$479,380Jerry D Glickson · University Of Pennsylvania · R01 · FY2021 · CA